What You'll Want to Know About Edwards Lifesciences' Stellar Q3 Earnings Results

Edwards Lifesciences (NYSE: EW) has been red-hot in 2019, breaking record highs on a routine basis. The company's transcatheter heart valve therapies (THVTs) continue to gain momentum in the marketplace. 

But Edwards' sizzling streak was on the line when the company announced its third-quarter results after the market closed on Wednesday. But any uncertainty was only temporary. Edwards Lifesciences once again gave investors a lot to like. Here's what you'll want to know about the medical-device maker's Q3 results.

Image Source: Getty Images

Continue reading

Source Fool.com